FTC action on PBMs could be just what the doctor ordered to improve patient outcomes
The FTC’s investigation into the business practices of PBMs could expose the outsized influence PBMs have on access to and the affordability of drugs. Read more in Medical Economics: FTC action on PBMs could be just what the doctor ordered to improve patient outcomes (medicaleconomics.com)